Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Bennett

Showing results (361-370 of 388) with videos related to

Pageof 39
Sort By:
Leukemia|January 1, 1992
Escalating the intensity of post-remission therapy improves the outcome in acute myeloid leukemia: the ECOG experience. The Eastern Cooperative Oncology GroupP A Cassileth, J W Andersen, J M Bennett, et al.
Annals of Internal Medicine|April 15, 1989
Chronic lymphocytic leukemia: recommendationsB D Cheson, J M Bennett, K R Rai, et al.
American Journal of Hematology|November 1, 1988
Guidelines for clinical protocols for chronic lymphocytic leukemia: recommendations of the National Cancer Institute-sponsored working groupB D Cheson, J M Bennett, K R Rai, et al.
Blood|September 6, 2001
Myelodysplastic syndromes standardized response criteria: further definitionB D Cheson, J M Bennett, H Kantarjian, et al.
Cancer|October 1, 1983
Sequential cyclophosphamide-prednisone and vincristine-bleomycin (CPOB). An effective, schedule-dependent treatment for advanced diffuse histiocytic lymphomaG J Johnson, W G Costello, M M Oken, et al.
Current Topics in Microbiology and Immunology|February 24, 2001
Expression of cyclooxygenase-2 and prostaglandins by B-1 cells and B-CLL cellsR P Phipps, S J Pollock, K Kaur, et al.
The New England Journal of Medicine|December 3, 1998
Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remissionP A Cassileth, D P Harrington, F R Appelbaum, et al.
Cancer Treatment Reports|May 1, 1976
Mechlorethamine (NSC-762) plus CCNU (NSC-79037) in the treatment of inoperable squamous and large cell carcinoma of the lungJ H Edmonson, S Lagakos, L Stolbach, et al.
Blood|October 26, 2000
Long-term follow-up of remission duration, mortality, and second malignancies in hairy cell leukemia patients treated with pentostatinI W Flinn, K J Kopecky, M K Foucar, et al.
Leukemia|October 14, 2014
Immunosuppressive therapy of LGL leukemia: prospective multicenter phase II study by the Eastern Cooperative Oncology Group (E5998)T P Loughran, L Zickl, T L Olson, et al.
Pageof 39

Showing results (361-370 of 388) with videos related to

Sort By:
Pageof 39
Leukemia|January 1, 1992
Escalating the intensity of post-remission therapy improves the outcome in acute myeloid leukemia: the ECOG experience. The Eastern Cooperative Oncology GroupP A Cassileth, J W Andersen, J M Bennett, et al.
Annals of Internal Medicine|April 15, 1989
Chronic lymphocytic leukemia: recommendationsB D Cheson, J M Bennett, K R Rai, et al.
American Journal of Hematology|November 1, 1988
Guidelines for clinical protocols for chronic lymphocytic leukemia: recommendations of the National Cancer Institute-sponsored working groupB D Cheson, J M Bennett, K R Rai, et al.
Blood|September 6, 2001
Myelodysplastic syndromes standardized response criteria: further definitionB D Cheson, J M Bennett, H Kantarjian, et al.
Cancer|October 1, 1983
Sequential cyclophosphamide-prednisone and vincristine-bleomycin (CPOB). An effective, schedule-dependent treatment for advanced diffuse histiocytic lymphomaG J Johnson, W G Costello, M M Oken, et al.
Current Topics in Microbiology and Immunology|February 24, 2001
Expression of cyclooxygenase-2 and prostaglandins by B-1 cells and B-CLL cellsR P Phipps, S J Pollock, K Kaur, et al.
The New England Journal of Medicine|December 3, 1998
Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remissionP A Cassileth, D P Harrington, F R Appelbaum, et al.
Cancer Treatment Reports|May 1, 1976
Mechlorethamine (NSC-762) plus CCNU (NSC-79037) in the treatment of inoperable squamous and large cell carcinoma of the lungJ H Edmonson, S Lagakos, L Stolbach, et al.
Blood|October 26, 2000
Long-term follow-up of remission duration, mortality, and second malignancies in hairy cell leukemia patients treated with pentostatinI W Flinn, K J Kopecky, M K Foucar, et al.
Leukemia|October 14, 2014
Immunosuppressive therapy of LGL leukemia: prospective multicenter phase II study by the Eastern Cooperative Oncology Group (E5998)T P Loughran, L Zickl, T L Olson, et al.
Pageof 39